Physician profile
Thomas N Levin
NPI 1295773414
$13,591.95
in general payments reported to CMS, 2019-2025
38 companies · $5,007 in 2025
The $5,007 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $417 · 2021: $2,234 · 2022: $1,652 · 2023: $1,508 · 2024: $1,800 · 2025: $5,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,677 · Travel and Lodging: $2,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,676.91 |
| Travel and Lodging | $2,637.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,922.29 | 2025 | Indigo System, Penumbra System |
| Abiomed | $1,217.74 | 2019-2025 | Impella |
| Biotronik INC. | $897.81 | 2021-2024 | Orsiro Mission, Recross, Nhancer Rx |
| Cardiovascular Systems INC. | $819.93 | 2019-2023 | Diamondback Coronary |
| Medtronic, INC. | $709.34 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Siemens Medical Solutions USA, INC. | $676.04 | 2020-2021 | |
| Boston Scientific Corporation | $599.17 | 2019-2025 | Stingray, Avvigo Guidance System, Watchman Access System |
| Janssen Pharmaceuticals, INC | $545.09 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $499.80 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tactile Systems Technology INC | $488.11 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Novartis Pharmaceuticals Corporation | $482.85 | 2019-2025 | |
| Abbott Laboratories | $465.35 | 2021-2024 | Diamondback Coronary, Mitraclip |
| Edwards Lifesciences Corporation | $405.63 | 2019-2025 | Sapien 3 Ultra Resilia |
| Terumo Medical Corporation | $364.02 | 2019-2023 | Glidewire |
| Shockwave Medical, INC | $273.03 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $260.66 | 2019-2025 | Repatha, Repatha |
| Imperative Care, INC | $203.63 | 2024-2025 | Symphony Catheter |
| Endologix LLC | $197.02 | 2025 | Endocross Device, Torus Stent Graft System |
| Esperion Therapeutics, INC. | $194.12 | 2021-2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $182.67 | 2019-2021 | |
| Atricure, INC. | $178.37 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Novo Nordisk INC | $146.24 | 2021-2024 | Ozempic, Wegovy, Rybelsus |
| Organogenesis INC. | $145.59 | 2025 | Puraply Wound Matrix |
| Cardiva Medical, INC. | $135.60 | 2024-2025 | Savvywire, Optowire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.69 | 2022-2023 | Jardiance |
| Heartflow, INC. | $86.78 | 2024-2025 | |
| Philips North America LLC | $78.24 | 2023 | |
| Medtronic Vascular, INC. | $76.63 | 2019 | |
| Pfizer INC. | $60.78 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.74 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $42.70 | 2021-2025 | Camzyos |
| Teleflex LLC | $29.50 | 2024 | Turnpike |
| Angiodynamics, INC. | $22.47 | 2025 | Alphavac |
| Merck Sharp & Dohme LLC | $16.31 | 2025 | Verquvo |
| Chiesi USA, INC. | $16.22 | 2023 | Kengreal |
| Cordis US Corp. | $15.79 | 2025 | Mynx Control Venous |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.